Ledger.Open graph →
SEC Form D · filed December 11, 2020

Enalare Therapeutics Inc

Offering
$5.0M
Sold
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
PRINCETON, NJ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Herman Cukier · Princeton, NJExec · DirectorDaniel Motto · Princeton, NJExecJoseph Pergolizzi · Naples, FLExec · DirectorGino Santini · Princeton, NJDirectorRobert Yedid · Princeton, NJDirectorJoseph Petko · Princeton, NJDirectorBrenden M. Smith · Mill Valley, CAExec · DirectorAnthony Morena · NY, NYDirectorKhalid Naeem · Vancouver, British Columbia, CanadaDirectorScott Cohen · Brooklyn, NYExecAlana Palmedo · San Francisco, CADirectorReena Jashnani-Slusarz · San Francisco, CAExec · DirectorPatrick Duncan · Charleston, SCDirectorDavid B. Rendina · Jupiter, FLExec · DirectorHaitham Al-Beik · MARLBOROUGH, MAExec · DirectorHari Rao · MARLBOROUGH, MADirectorGreg Litvak · Denver, COExecDaniel Zinn · Santa Monica, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗